CLINICAL TRIALS BY STATE

Clinical Trials in Vermont

12+ recruiting studies in Vermont, sourced in real time from ClinicalTrials.gov and displayed in plain English.

BROWSE BY CONDITION IN VERMONT

Bladder CancerBrain Tumor / GliomaBreast CancerCervical CancerColorectal CancerEndometrial / Uterine CancerHead & Neck CancerKidney / Renal Cell CarcinomaLeukemia (AML)Leukemia (CLL)Liver / Hepatocellular CarcinomaLung Cancer (NSCLC)Lung Cancer (SCLC)Lymphoma (Non-Hodgkin)MelanomaMultiple MyelomaOvarian CancerPancreatic Cancer

RECRUITING TRIALS IN VERMONT

RECRUITING

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

NCT06692894 · Burlington, University of Vermont
RECRUITING

PumaRx Registry Trial

NCT06805461 · Coral Gables, Baptist Health South Florida
RECRUITINGPhase 3

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

NCT06141486 · Birmingham, Alabama Neurology Associates- Site Number : 8400115
RECRUITINGPhase 2

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

NCT06616584 · Daphne, Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis
RECRUITINGPhase 3

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

NCT06890598 · Huntsville, Clearview Cancer Institute
RECRUITINGPhase 2

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

NCT04858334 · Anchorage, Anchorage Associates in Radiation Medicine
RECRUITINGPhase 3

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

NCT03488693 · Fairbanks, Fairbanks Memorial Hospital
RECRUITINGPhase 3

A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

NCT06290128 · Homewood, Alabama Neurology Associates- Site Number : 8400019
RECRUITINGPhase 3

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

NCT07000357 · Birmingham, Research Site
RECRUITINGPhase 3

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

NCT06708299 · Phoenix, Mayo Clionic Arizona
RECRUITINGPhase 2

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

NCT06317649 · Tucson, Banner University Medical Center - Tucson
RECRUITINGPhase 3

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

NCT06592924 · Anchorage, Anchorage Associates in Radiation Medicine

COMMON QUESTIONS

How many clinical trials are available in Vermont?

There are currently 12+ recruiting clinical trials in Vermont listed on ClinicalTrials.gov. Clinicals AI makes these easier to browse with plain-language summaries and condition filters.

How do I join a clinical trial in Vermont?

Browse the listings above, review eligibility criteria, and submit a contact request. A study coordinator will follow up to discuss your eligibility and next steps.

Are clinical trials in Vermont free?

Most trials cover the investigational treatment and study-related visits at no cost. Some also offer compensation for time and travel. Confirm cost details with each trial coordinator.

What conditions have trials in Vermont?

Vermont hosts trials across cancer, cardiovascular disease, diabetes, neurological conditions, mental health, autoimmune disease, and rare conditions. Browse by condition using the links above.

OTHER STATES

CaliforniaNew YorkTexasFloridaPennsylvaniaOhioIllinoisMassachusettsMichiganWashington